Sfoglia per Autore
Will pharmacogenetic findings influence our everyday clinical practice?
2004 Serretti A.
The pharmacogenomics of selective serotonin reuptake inhibitors.
2004 Serretti A.; Artioli P.
From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.
2004 Serretti A.; Artioli P.
Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.
2004 Serretti A.; Artioli P.; Zanardi R.; Lorenzi C.; Rossini D.; Cusin C.; Arnoldi A.; Catalano M.
Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study.
2004 Mendlewicz J.; Massat I.; Souery D.; Del-Favero J.; Oruc L.; Nothen M.M.; Blackwood D.; Muir W.; Battersby S.; Lerer B.; Segman R.H.; Kaneva R.; Serretti A.; Lilli R.; Lorenzi C.; Jakovljevic M.; Ivezic S.; Rietschel M.; Milanova V.; Van Broeckhoven C.
A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder.
2004 Benedetti; F.; Bernasconi; A.; Lorenzi; C.; Pontiggia; A.; Serretti; A.; Colombo; C.; Smeraldi; E.
Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
2004 Serretti A.; Zanardi R.; Franchini L.; Artioli P.; Dotoli D.; Pirovano A.; Smeraldi E.
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.
2004 Serretti A.; Cusin C.; Rossini D.; Artioli P.; Dotoli D.; Zanardi R.
The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.
2004 Serretti A.; Artioli P.; Lorenzi C.; Pirovano A.; Tubazio V.; Zanardi R.
Genetic polymorphisms influencing response of antidepressants
2004 Serretti A.; Lorenzi C.; Benedetti F.; Pirovano A.; Zanardi R.; Colombo C.; Ploia C.; Tubazio V.; Smeraldi E.
Demographic and clinical features of mood disorders.
2004 Serretti A.; Mandelli L.
A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.
2004 Benedetti F.; Serretti A.; Colombo C.; Lorenzi C.; Tubazio V.; Smeraldi E.
A targeted use of DNA microarrays in the pharmacogenetics of antidepressants: pros and cons
2004 Lorenzi C.; Tubazio V.; Ploia C.; Serretti A.; De Ronchi D.;
Pharmacogenetics of antidepressants efficacy
2004 Serretti A.
Aspetti Genetici e Familiari
2004 Serretti A.
Neural network analysis in pharmacogenetics of mood disorders.
2004 Serretti A.; Smeraldi E.
The 5-HT2C receptor as a target for mood disorders.
2004 Serretti A; Artioli P; De Ronchi D.
DRD4 exon 3 variants are not associated with symptomatology of major psychoses in a German population.
2004 Serretti A.; Lorenzi C.; Mandelli L.; Cichon S.; Schumacher J.; Nothen M.M.; Rietschel M.; Tullius M.; Ohlraun S.
BanI Polymorphism of the Cytosolic Phospholipase A(2) Gene and Mood Disorders in the Korean Population.
2004 Pae C.U.; Yu H.S.; Kim J.J.; Lee C.U.; Lee S.J.; Lee K.U.; Jun T.Y.; Paik I.H.; Serretti A.; Lee C.
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and schizophrenia in the Korean population.
2004 Pae C.U.; Chung K.I.; Kim J.J.; Yu H.S.; Lee C.U.; Lee S.J.; Lee C.; Jun T.Y.; Serretti A.; Paik I.H.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile